MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Behavioral abnormalities"

  • 2023 International Congress

    Needs and priorities of people with Parkinson’s and care partners regarding neuropsychiatric symptoms

    J. Goldman, H. Peirce, D. Merkitch (Chicago, USA)

    Objective: To examine the experiences of people with Parkinson’s disease (PD) and care partners (CPs) regarding cognitive, mood, behavioral, and sleep issues. Background: Neuropsychiatric symptoms…
  • 2023 International Congress

    Tramadol Induces Neuroinflammation, Mitochondrial Oxidative Stress, Neurotransmitters Dysbalanced and Produced Parkinson’s Disease Like Symptoms in Experimental Wistar Rats

    KHA. Aran (Moga, India)

    Objective: The current study is designed to evaluate the possible neurotoxic effects of tramadol in Wistar rats. Background: Parkinson’s disease (PD) is a chronic neurodegenerative…
  • 2023 International Congress

    Specific Parkinson’s disease phenotype in patients with long term PTSP

    I. šarac, H. šarac, N. Henigsberg, F. Borovečki, Z. Krešić, I. Ivek, T. Sukobljević (Zagreb, Croatia)

    Objective: to describe possibly specific clinical phenotype of PD patients who suffered from long-term postraumatic-stress-disorders (PTSD Background: There is enough evidence about the relationship between…
  • 2023 International Congress

    Diffusion imaging study of mild behavioral impairment in Parkinson’s disease.

    H. Almgren, M. Descoteaux, M. Ghahremani, Z. Ismail, O. Monchi (Calgary, Canada)

    Objective: Patients with Parkinson’s disease (PD) experience changes in behavior, personality, and cognition. Mild Behavioral Impairment (MBI) is a validated neurobehavioral syndrome that identifies a…
  • 2023 International Congress

    Therapeutic effects of citral nanoliposome on Parkinson’s treatment in a rat model: Modulation via neurochemical, inflammatory and antioxidant pathways

    N. Moradikor, M. Haghipanah, W. Mohamed (Tbilisi, Georgia)

    Objective: The present study aimed to assess the effects of citral nanoliposome on Parkinson's treatment in a rat model. Background: Parkinson's disease is the most…
  • 2023 International Congress

    Severe movement disorder initially suspected of being conversion – key insights from the psychiatrist

    L. Jaffe (Honolulu, USA)

    Objective: The review of a case diagnosed as Conversion Disorder (CD) in a University Movement Disorders clinic is presented here.  As this patient eventually recovered…
  • 2022 International Congress

    Protective approach targeting NF-kB/ Nrf2 signaling and neuroinflammation using Apigenin in LPS induced Parkinsonism in experimental rats

    S. Singh (Moga, India)

    Objective: 1. Apigenin as a protective strategy to prevent neuroinflammation in PD.2. To find behavioral, neurochemical and histopathological changes in LPS induced PD. Background: Parkinson’s…
  • 2022 International Congress

    Cognitive and Motor aspects of a Brazilian population with Parkinson´s disease and Impulse Control Disorders and/or Related Behaviors – an observational study.

    B. Veiga, C. da Silva, L. Barcelos, H. Ferraz, S. Silva, V. Borges (São Paulo, Brazil)

    Objective: We analysed if Impulse Control Disorders (ICDs) and/or Related Behaviors (RBs) were associated with levodopa-induced dyskinesia (LIDs) in Brazilian patients with Parkinson´s disease (PD)…
  • 2022 International Congress

    Contribution of external globus pallidus to motor deficits of Parkinson’s disease: optogenetic studies in murine model

    S. Dibisceglie Caballero, A. Ces, F. Ambroggi, M. Amalric, A. Ouagazzal (Marseille, France)

    Objective: The present study explored whether altered activity of external globus pallidus (GPe) neurons contributes to the development of motor deficits of Parkinson’s disease (PD).…
  • 2022 International Congress

    Phantom Pregnancy – A Novel Impulse Control Behaviour in Parkinson’s Disease: A Case Report

    H. Martin, L. Teare (Coventry, United Kingdom)

    Objective: A case report of a phantom pregnancy in a patient with Parkinson’s disease (PD) resulting from impulse control behaviour. Background: Impulse Control Disorders (ICDs)…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • …
  • 15
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • AI-Powered Detection of Freezing of Gait Using Wearable Sensor Data in Patients with Parkinson’s Disease
    • Effect of marijuana on Essential Tremor: A case report
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
    • Patients with Essential Tremor Live Longer than their Relatives
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley